Evidence map›Paper›PMID 40065909›Full record

ArticleJournal of inflammation research2025

Adenosine A2A Receptor Activation Alleviated Disease of Mice with Systemic

Xia-Nan Wu, Ke Dong, Yan Liu, Lan Yang, Jing Zhang, Ming Yang, Zhao-Wei Gao

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. AMetabolites · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xia-Nan Wu *Department of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Ke Dong *Department of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Yan LiuDepartment of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Lan YangDepartment of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Jing ZhangDepartment of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Ming YangDepartment of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.
Zhao-Wei GaoDepartment of Clinical Laboratory, Tangdu Hospital, Airforce Medical University, Xi'an, Shaanxi, People's Republic of China.ORCID 0000-0003-4477-0966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The incidence of candidemia, mediated by systemic Methods: The candidemia mice models (named CA mice) were established by tail intravenous injection of Results: In CA mice, we observed that NECA and A2AR agonist treatment significantly alleviated the sepsis score and increased the survival rate. Moreover, the renal injury and fungal load were reduced by NECA and A2AR agonist treatment. However, the other adenosine receptors (ie, A1R, A2BR and A3R) activation have no effect on survival and tissue damage of CA mice. A2AR activation could reduce macrophage infiltration in kidney and the production of inflammatory cytokine IL-6 in CA mice. Moreover, adenosine-A2AR signaling activation could enhance antifungal capacity of macrophages and promoted macrophage polarization toward the M2 subtype. Conclusion: Activation of adenosine-A2AR axis promoted macrophage M2 polarization, enhanced host defense against systemic

Indexed as

adenosine receptorC. albicansmacrophagerenal injurysystemic infection

Identifiers

PMID40065909
PMCPMC11892491

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.